FilingReader Intelligence
Zhongsheng Pharmaceutical to redeem subsidiary equity for $35m
July 31, 2025 at 05:25 PM UTC•By FilingReader AI
Guangdong Zhongsheng Pharmaceutical will redeem 2.86% equity in subsidiary Zhongsheng Ruichuang for 20m yuan and $15.15m after the unit failed to achieve a qualified listing by December 31, 2024.
The company's stake will increase from 74.26% to 77.12%.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SZSE:002317•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Guangdong Zhongsheng Pharmaceutical publishes news
Free account required • Unsubscribe anytime